To validate the specificity of T cell-mediated cytotoxicity toward tumor cells, B16-OVA melanoma cells were pre-stained with CellTrace Violet prior to co-culturing with BMDCs and CD8+ T cells. The gene discussed is CD8A; the disease is melanoma.